SynopsisThe global Surface Plasmon Resonance System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030. North American market for Surface Plasmon Resonance System i.....
SynopsisThe global Bioartificial Renal Assist Devices market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026. This report focuses on Bioartificial Renal Assist Devices vol.....
SynopsisThe global Absorbable Biomaterial Pericardial Membrane market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030. Technological innovation: With the continuous adv.....
SynopsisAtrial septal defect (ASD) is one of the most common congenital heart defects requiring procedural intervention. ASD closure devices are intended to close openings between the atria (the two upper chambers of the heart). It can be used to treat patients with c.....
SynopsisThe EVH systems segment accounted for the largest share in 2017 and is expected to register the highest CAGR during the forecast period. This can be primarily attributed to the rising adoption of minimally invasive procedures for vessel harvesting and disposab.....
SynopsisThe global Abdominal Aorta Stent Graft System market was valued at US$ 3202.6 million in 2023 and is anticipated to reach US$ 4006.9 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030. North American market for Abdominal Aort.....
SynopsisImplantable Blood Glucose Monitor is implanted subcutaneously into the upper arm under local anesthesia, the system allows for replacement of finger stick blood glucose measures. The global Implantable Blood Glucose Monitor market was valued at US$ 39 mi.....
SynopsisPalonosetron (INN, trade name Aloxi) is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV). The global Palonosetron market was valued at US$ 113 million in 2023 and is anticipated to reach US$ 147.6.....
SynopsisThe global Alzheimer’s Agitation Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022.....
Synopsis Drugs for the treatment of primary immunodeficiency diseases Highlights The global Primary Immunodeficiency Drugs market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of.....
